I agree that this site is using cookies. You can find further informations here.
X
IJzerman, Maarten J.
480  results:
Search for persons X
?
1

Real World Treatment and Outcomes in ALK-rearranged Non-sma..:

Chazan, Grace ; Franchini, Fanny ; Shah, Roma...
JTO Clinical and Research Reports.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Paving the path for implementation of clinical genomic sequ..:

Marshall, Deborah A ; Hua, Nicolle ; Buchanan, James...
Health Affairs Scholar.  2 (2024)  5 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
3

Comparing modeling strategies combining changes in multiple..:

van Delft, Frederik A. ; Schuurbiers, Milou M.F. ; Muller, Mirte...
Tumor Biology.  46 (2024)  s1 - p. S269-S281 , 2024
Link: https://doi.org/10.3233/..
 
?
4

Whole genome sequencing as a ticket to cancer treatment in ..:

Smids, Jilles ; Bomhof, Charlotte ; IJzerman, Maarten.
Journal of Cancer Policy.  41 (2024)  - p. 100492 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Health economic evidence for adjuvant chemotherapy in stage..:

To, Yat Hang ; Gibbs, Peter ; Tie, Jeanne..
Cost Effectiveness and Resource Allocation.  21 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
6

Systematic review of NTRK 1/2/3 fusion prevalence pan-cance..:

O'Haire, Sophie ; Franchini, Fanny ; Kang, Yoon-Jung...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

Quantifying hospital-associated costs, and accompanying tra..:

Florax, Anna A ; Doeleman, Martijn J H ; de Roock, Sytze...
Rheumatology.  , 2023
Link: https://doi.org/10.1093/..
 
?
8

Patient and healthcare professional acceptability of pharma..:

Glewis, Sarah ; Krishnasamy, Mei ; Lingaratnam, Senthil...
Clinical and Translational Science.  16 (2023)  12 - p. 2700-2708 , 2023
Link: https://doi.org/10.1111/..
 
?
9

Developing and validating a multi-criteria decision analyti..:

Gillett, Piers ; Mahar, Robert K ; Tran, Nancy R..
Cost Effectiveness and Resource Allocation.  21 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
10

Population-Based Screening Using Low-Dose Chest Computed To..:

Behr, Carina M. ; Oude Wolcherink, Martijn J. ; IJzerman, Maarten J...
PharmacoEconomics.  41 (2023)  4 - p. 395-411 , 2023
Link: https://doi.org/10.1007/..
 
?
11

The effect of time before diagnosis and treatment on colore..:

Drosdowsky, Allison ; Lamb, Karen E. ; Karahalios, Amalia...
British Journal of Cancer.  129 (2023)  6 - p. 993-1006 , 2023
Link: https://doi.org/10.1038/..
 
?
12

Cost Effectiveness of Molecular Diagnostic Testing Algorith..:

Vu, Martin ; Degeling, Koen ; Thompson, Ella R....
Applied Health Economics and Health Policy.  22 (2023)  1 - p. 107-122 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Implementing competing risks in discrete event simulation: ..:

Franchini, Fanny ; Fedyashov, Victor ; IJzerman, Maarten J..
Frontiers in Pharmacology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
14

A systematic review of methodological considerations in tim..:

Drosdowsky, Allison ; Lamb, Karen E. ; Bergin, Rebecca J....
Cancer Epidemiology.  83 (2023)  - p. 102323 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Health Economic Evidence and Modeling Challenges for Liquid..:

Fagery, Mussab ; Khorshidi, Hadi A. ; Wong, Stephen Q...
PharmacoEconomics.  41 (2023)  10 - p. 1229-1248 , 2023
Link: https://doi.org/10.1007/..
 
1-15